February 01, 2015 18:58 (IST)
The company, which is pursuing R&D in both novel biologics as well as biosimilars (generic versions of biologic drugs), in various stages of trials, had spent around Rs 131 crore on R&D in the previous fiscal year which was 6 per cent of biopharma sales.
January 31, 2015 19:13 (IST)
Divis Laboratories Ltd plans to invest Rs 500 crore in Andhra Pradesh to set up its third manufacturing facility as it looks to augment its production capacity.
January 31, 2015 11:52 (IST)
Sun Pharmaceutical Industries Ltd has won US approval to buy Ranbaxy Laboratories Ltd on condition that it will sell its interest in a generic antibacterial medicine, the US Federal Trade Commission said on Friday.
January 30, 2015 17:34 (IST)
"The company's Oral Dosage Facility (KRS Gardens) at Bangalore has been found acceptable by the United States Food and Drug Administration (US FDA)," Strides Arcolab said in a filing to BSE.
January 27, 2015 16:36 (IST)
Drug major Ranbaxy on Tuesday said that the US Food and Drug Administration or FDA has "determined" that the Indian drug manufacturer has forfeited its 180 days exclusivity for stomach and esophagus problems treatment tablets.
January 22, 2015 16:18 (IST)
The board had earlier constituted a securities issue committee comprising of five board members, including two independent directors, for issue of securities.
January 20, 2015 19:13 (IST)
According to notification by the US Food and Drug Administration (USFDA), the Indian firm's arm Aurobindo Pharma USA Inc has initiated a Class II nation wide recall. Each bottle contains 100 capsules of 300 mg.
January 17, 2015 11:44 (IST)
Novartis AG is closing its manufacturing plant in Puerto Rico as part of a major overhaul of its business.
January 14, 2015 23:36 (IST)
Hamsons, a firm owned by the promoter family of pharmaceuticals major Cipla, has bought out the remaining 21 per cent equity owned by minority shareholders in Satara-based Okasa Pharma for an undisclosed amount, completing the process it started last September.
January 14, 2015 23:26 (IST)
India's patent office has rejected an application from US-based Gilead Sciences Inc for its hepatitis C drug Sovaldi, paving the way for local drug makers to launch cheaper generic versions of the $1,000-a-pill medicine.
January 14, 2015 19:41 (IST)
A bench of justices Badar Durrez Ahmed and Sanjeev Sachdeva, however, refused to pass any interim order to allow Cipla to manufacture its Indacaterol-based drug saying, it will give an early hearing to the matter.
January 10, 2015 16:01 (IST)
Cipla has expressed disappointment over a Delhi High Court order restraining the drug maker from manufacturing and selling any medicine containing 'Indacaterol', saying that the interim verdict would deny patients access to the drugs they need.
January 09, 2015 20:22 (IST)
The Delhi High Court on Friday temporarily restrained Cipla from manufacturing, importing or selling any drug containing the chemical Indacaterol which is used for treatment of chronic obstructive pulmonary disease (COPD) till it obtains a compulsory licence for the medicine.
January 08, 2015 19:47 (IST)
Drug firm Cadila Healthcare is voluntarily recalling 19,536 bottles of benzonatate capsules, used to treat cough, in the US due to "wet and/or leaking capsules".
December 30, 2014 18:18 (IST)
Drug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in the US, according to the US Food and Drug Administration (FDA).
December 30, 2014 18:02 (IST)
Drug firm Lupin has received a tentative approval from the US Food and Drug Administration (FDA) to market a generic version of Prezista tablets used in treating HIV infection.
December 27, 2014 17:41 (IST)
It has been a year of bitter medicine for Indian pharmaceutical companies with fines worth millions of dollars imposed by various foreign regulators, even as they stitched together deals worth billions of dollars, including a high profile merger between Sun Pharma and Ranbaxy.
December 26, 2014 15:59 (IST)
Drug major Lupin has received approval of the US Food and Drug Administration (FDA) to market a generic version of ViiV Healthcare's 'Epivir' tablets, used in treating HIV infection, in the American market. Shares in Lupin rose nearly 1 per cent during the day.
December 24, 2014 20:27 (IST)
Medical device makers on Wednesday welcomed the government's decision to allow up to 100 per cent foreign direct investment or FDI in the sector under automatic route, saying the move would boost technology inflow and manufacturing.
December 24, 2014 14:36 (IST)
The government has made it easier for foreigners to fully own existing medical device makers in India, in a bid to boost investment in the $7-billion sector.